270 related articles for article (PubMed ID: 35027915)
1. Chamaejasmenin B, an Inhibitor for Metastatic Outgrowth, Reversed M2-Dominant Macrophage Polarization in Breast Tumor Microenvironment.
Li Q; Sun L; Liu L; Ran Q; Du X; Yang Q; Wang Y; Li Y; Chen Y; Weng X; Cai W; Zhu X
Front Immunol; 2021; 12():774230. PubMed ID: 35027915
[TBL] [Abstract][Full Text] [Related]
2. M2 polarization of macrophages by Oncostatin M in hypoxic tumor microenvironment is mediated by mTORC2 and promotes tumor growth and metastasis.
Shrivastava R; Asif M; Singh V; Dubey P; Ahmad Malik S; Lone MU; Tewari BN; Baghel KS; Pal S; Nagar GK; Chattopadhyay N; Bhadauria S
Cytokine; 2019 Jun; 118():130-143. PubMed ID: 29625858
[TBL] [Abstract][Full Text] [Related]
3. Chamaejasmenin B, a novel candidate, inhibits breast tumor metastasis by rebalancing TGF-beta paradox.
Li Q; Wang Y; Xiao H; Li Y; Kan X; Wang X; Zhang G; Wang Z; Yang Q; Chen X; Weng X; Chen Y; Zhou B; Guo Y; Liu X; Zhu X
Oncotarget; 2016 Jul; 7(30):48180-48192. PubMed ID: 27374079
[TBL] [Abstract][Full Text] [Related]
4. Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer.
Esser AK; Ross MH; Fontana F; Su X; Gabay A; Fox GC; Xu Y; Xiang J; Schmieder AH; Yang X; Cui G; Scott M; Achilefu S; Chauhan J; Fletcher S; Lanza GM; Weilbaecher KN
Theranostics; 2020; 10(17):7510-7526. PubMed ID: 32685002
[TBL] [Abstract][Full Text] [Related]
5. Autophagy suppresses isoprenaline-induced M2 macrophage polarization via the ROS/ERK and mTOR signaling pathway.
Shan M; Qin J; Jin F; Han X; Guan H; Li X; Zhang J; Zhang H; Wang Y
Free Radic Biol Med; 2017 Sep; 110():432-443. PubMed ID: 28647611
[TBL] [Abstract][Full Text] [Related]
6. Matrix-Targeting Immunotherapy Controls Tumor Growth and Spread by Switching Macrophage Phenotype.
Deligne C; Murdamoothoo D; Gammage AN; Gschwandtner M; Erne W; Loustau T; Marzeda AM; Carapito R; Paul N; Velazquez-Quesada I; Mazzier I; Sun Z; Orend G; Midwood KS
Cancer Immunol Res; 2020 Mar; 8(3):368-382. PubMed ID: 31941671
[TBL] [Abstract][Full Text] [Related]
7. ICAM-1 suppresses tumor metastasis by inhibiting macrophage M2 polarization through blockade of efferocytosis.
Yang M; Liu J; Piao C; Shao J; Du J
Cell Death Dis; 2015 Jun; 6(6):e1780. PubMed ID: 26068788
[TBL] [Abstract][Full Text] [Related]
8. Diverse macrophages polarization in tumor microenvironment.
Rhee I
Arch Pharm Res; 2016 Nov; 39(11):1588-1596. PubMed ID: 27562774
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of triggering receptor expressed on myeloid cells 1 inhibits invasion and migration of liver cancer cells by mediating macrophage polarization.
Chen M; Lai R; Lin X; Chen W; Wu H; Zheng Q
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649843
[TBL] [Abstract][Full Text] [Related]
10. MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment.
Fang DD; Tang Q; Kong Y; Wang Q; Gu J; Fang X; Zou P; Rong T; Wang J; Yang D; Zhai Y
J Immunother Cancer; 2019 Nov; 7(1):327. PubMed ID: 31779710
[TBL] [Abstract][Full Text] [Related]
11. Emodin Inhibits Breast Cancer Growth by Blocking the Tumor-Promoting Feedforward Loop between Cancer Cells and Macrophages.
Iwanowycz S; Wang J; Hodge J; Wang Y; Yu F; Fan D
Mol Cancer Ther; 2016 Aug; 15(8):1931-42. PubMed ID: 27196773
[TBL] [Abstract][Full Text] [Related]
12. Emodin suppresses pulmonary metastasis of breast cancer accompanied with decreased macrophage recruitment and M2 polarization in the lungs.
Jia X; Yu F; Wang J; Iwanowycz S; Saaoud F; Wang Y; Hu J; Wang Q; Fan D
Breast Cancer Res Treat; 2014 Nov; 148(2):291-302. PubMed ID: 25311112
[TBL] [Abstract][Full Text] [Related]
13. Astragaloside IV antagonizes M2 phenotype macrophage polarization-evoked ovarian cancer cell malignant progression by suppressing the HMGB1-TLR4 axis.
Wang X; Gao S; Song L; Liu M; Sun Z; Liu J
Mol Immunol; 2021 Feb; 130():113-121. PubMed ID: 33308900
[TBL] [Abstract][Full Text] [Related]
14. Sphingomyelin synthase 2 facilitates M2-like macrophage polarization and tumor progression in a mouse model of triple-negative breast cancer.
Deng Y; Hu JC; He SH; Lou B; Ding TB; Yang JT; Mo MG; Ye DY; Zhou L; Jiang XC; Yu K; Dong JB
Acta Pharmacol Sin; 2021 Jan; 42(1):149-159. PubMed ID: 32451413
[TBL] [Abstract][Full Text] [Related]
15. Tumoral NOX4 recruits M2 tumor-associated macrophages via ROS/PI3K signaling-dependent various cytokine production to promote NSCLC growth.
Zhang J; Li H; Wu Q; Chen Y; Deng Y; Yang Z; Zhang L; Liu B
Redox Biol; 2019 Apr; 22():101116. PubMed ID: 30769285
[TBL] [Abstract][Full Text] [Related]
16. Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer.
Li D; Ji H; Niu X; Yin L; Wang Y; Gu Y; Wang J; Zhou X; Zhang H; Zhang Q
Cancer Sci; 2020 Jan; 111(1):47-58. PubMed ID: 31710162
[TBL] [Abstract][Full Text] [Related]
17. CAA-derived IL-6 induced M2 macrophage polarization by activating STAT3.
Zhao C; Zeng N; Zhou X; Tan Y; Wang Y; Zhang J; Wu Y; Zhang Q
BMC Cancer; 2023 May; 23(1):392. PubMed ID: 37127625
[TBL] [Abstract][Full Text] [Related]
18. A High Dose of Calcitriol Inhibits Glycolysis and M2 Macrophage Polarization in the Tumor Microenvironment by Repressing mTOR Activation: in vitro and Molecular Docking Studies.
Munir MT; Halim SA; Santos JM; Khan F; Khan A; Rahman MM; Hussain F; Al-Harrasi A; Gollahon LS; Rahman SM
Cell Physiol Biochem; 2023 Apr; 57(2):105-122. PubMed ID: 37052042
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer.
Steenbrugge J; Breyne K; Demeyere K; De Wever O; Sanders NN; Van Den Broeck W; Colpaert C; Vermeulen P; Van Laere S; Meyer E
J Exp Clin Cancer Res; 2018 Aug; 37(1):191. PubMed ID: 30111338
[TBL] [Abstract][Full Text] [Related]
20. Metformin-treated cancer cells modulate macrophage polarization through AMPK-NF-κB signaling.
Chiang CF; Chao TT; Su YF; Hsu CC; Chien CY; Chiu KC; Shiah SG; Lee CH; Liu SY; Shieh YS
Oncotarget; 2017 Mar; 8(13):20706-20718. PubMed ID: 28157701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]